<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.jnanobiotechnology.com/feeds/mostaccessed/journal?quantity=&amp;format=rss&amp;version=">
        <title>Journal of Nanobiotechnology - Most accessed articles</title>
        <link>http://www.jnanobiotechnology.com</link>
        <description>The most accessed research articles published by Journal of Nanobiotechnology</description>
        <dc:date>2010-02-14T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/2/1/3" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/3/1/6" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/5/1/3" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/8/1/1" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/2/1/12" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/8/1/2" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/7/1/8" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/7/1/9" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/8/1/3" />
                                <rdf:li rdf:resource="http://www.jnanobiotechnology.com/content/4/1/10" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.jnanobiotechnology.com/content/2/1/3">
        <title>Applications of nanoparticles in biology and medicine</title>
        <description>Nanomaterials are at the leading edge of the rapidly developing field of nanotechnology. Their unique size-dependent properties make these materials superior and indispensable in many areas of human activity. This brief review tries to summarise the most recent developments in the field of applied nanomaterials, in particular their application in biology and medicine, and discusses their commercialisation prospects.</description>
        <link>http://www.jnanobiotechnology.com/content/2/1/3</link>
                <dc:creator>O Salata</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2004, 2:3</dc:source>
        <dc:date>2004-04-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-2-3</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2004-04-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/3/1/6">
        <title>Interaction of silver nanoparticles with HIV-1</title>
        <description>The interaction of nanoparticles with biomolecules and microorganisms is an expanding field of research. Within this field, an area that has been largely unexplored is the interaction of metal nanoparticles with viruses. In this work, we demonstrate that silver nanoparticles undergo a size-dependent interaction with HIV-1, with nanoparticles exclusively in the range of 1&#8211;10 nm attached to the virus. The regular spatial arrangement of the attached nanoparticles, the center-to-center distance between nanoparticles, and the fact that the exposed sulfur-bearing residues of the glycoprotein knobs would be attractive sites for nanoparticle interaction suggest that silver nanoparticles interact with the HIV-1 virus via preferential binding to the gp120 glycoprotein knobs. Due to this interaction, silver nanoparticles inhibit the virus from binding to host cells, as demonstrated in vitro.</description>
        <link>http://www.jnanobiotechnology.com/content/3/1/6</link>
                <dc:creator>Jose Luis Elechiguerra</dc:creator>
                <dc:creator>Justin Burt</dc:creator>
                <dc:creator>Jose Morones</dc:creator>
                <dc:creator>Alejandra Camacho-Bragado</dc:creator>
                <dc:creator>Xiaoxia Gao</dc:creator>
                <dc:creator>Humberto Lara</dc:creator>
                <dc:creator>Miguel Jose Yacaman</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2005, 3:6</dc:source>
        <dc:date>2005-06-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-3-6</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>3</prism:volume>
        <prism:startingPage>6</prism:startingPage>
        <prism:publicationDate>2005-06-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/5/1/3">
        <title>Polymeric nanoparticle-encapsulated curcumin (nanocurcumin): a novel strategy for human cancer therapy
</title>
        <description>Background:
Curcumin, a yellow polyphenol extracted from the rhizome of turmeric (Curcuma longa), has potent anti-cancer properties as demonstrated in a plethora of human cancer cell line and animal carcinogenesis models. Nevertheless, widespread clinical application of this relatively efficacious agent in cancer and other diseases has been limited due to poor aqueous solubility, and consequently, minimal systemic bioavailability. Nanoparticle-based drug delivery approaches have the potential for rendering hydrophobic agents like curcumin dispersible in aqueous media, thus circumventing the pitfalls of poor solubility.
Results:
We have synthesized polymeric nanoparticle encapsulated formulation of curcumin &#8211; nanocurcumin &#8211; utilizing the micellar aggregates of cross-linked and random copolymers of N-isopropylacrylamide (NIPAAM), with N-vinyl-2-pyrrolidone (VP) and poly(ethyleneglycol)monoacrylate (PEG-A). Physico-chemical characterization of the polymeric nanoparticles by dynamic laser light scattering and transmission electron microscopy confirms a narrow size distribution in the 50 nm range. Nanocurcumin, unlike free curcumin, is readily dispersed in aqueous media. Nanocurcumin demonstrates comparable in vitro therapeutic efficacy to free curcumin against a panel of human pancreatic cancer cell lines, as assessed by cell viability and clonogenicity assays in soft agar. Further, nanocurcumin&apos;s mechanisms of action on pancreatic cancer cells mirror that of free curcumin, including induction of cellular apoptosis, blockade of nuclear factor kappa B (NF&#954;B) activation, and downregulation of steady state levels of multiple pro-inflammatory cytokines (IL-6, IL-8, and TNF&#945;).
Conclusion:
Nanocurcumin provides an opportunity to expand the clinical repertoire of this efficacious agent by enabling ready aqueous dispersion. Future studies utilizing nanocurcumin are warranted in pre-clinical in vivo models of cancer and other diseases that might benefit from the effects of curcumin.</description>
        <link>http://www.jnanobiotechnology.com/content/5/1/3</link>
                <dc:creator>Savita Bisht</dc:creator>
                <dc:creator>Georg Feldmann</dc:creator>
                <dc:creator>Sheetal Soni</dc:creator>
                <dc:creator>Rajani Ravi</dc:creator>
                <dc:creator>Collins Karikari</dc:creator>
                <dc:creator>Amarnath Maitra</dc:creator>
                <dc:creator>Anirban Maitra</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2007, 5:3</dc:source>
        <dc:date>2007-04-17T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-5-3</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>5</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2007-04-17T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/8/1/1">
        <title>Mode of antiviral action of silver nanoparticles against HIV-1</title>
        <description>Background:
Silver nanoparticles have proven to exert antiviral activity against HIV-1 at non-cytotoxic concentrations, but the mechanism underlying their HIV-inhibitory activity has not been not fully elucidated. In this study, silver nanoparticles are evaluated to elucidate their mode of antiviral action against HIV-1 using a panel of different in vitro assays.
Results:
Our data suggest that silver nanoparticles exert anti-HIV activity at an early stage of viral replication, most likely as a virucidal agent or as an inhibitor of viral entry. Silver nanoparticles bind to gp120 in a manner that prevents CD4-dependent virion binding, fusion, and infectivity, acting as an effective virucidal agent against cell-free virus (laboratory strains, clinical isolates, T and M tropic strains, and resistant strains) and cell-associated virus. Besides, silver nanoparticles inhibit post-entry stages of the HIV-1 life cycle.
Conclusions:
These properties make them a broad-spectrum agent not prone to inducing resistance that could be used preventively against a wide variety of circulating HIV-1 strains.</description>
        <link>http://www.jnanobiotechnology.com/content/8/1/1</link>
                <dc:creator>Humberto Lara</dc:creator>
                <dc:creator>Nilda Ayala-Nunez</dc:creator>
                <dc:creator>Liliana Ixtepan-Turrent</dc:creator>
                <dc:creator>Cristina Rodriguez-Padilla</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2010, 8:1</dc:source>
        <dc:date>2010-01-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-8-1</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>1</prism:startingPage>
        <prism:publicationDate>2010-01-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/2/1/12">
        <title>Nanoparticles - known and unknown health risks</title>
        <description>Manmade nanoparticles range from the well-established multi-ton production of carbon black and fumed silica for applications in plastic fillers and car tyres to microgram quantities of fluorescent quantum dots used as markers in biological imaging. As nano-sciences are experiencing massive investment worldwide, there will be a further rise in consumer products relying on nanotechnology. While benefits of nanotechnology are widely publicised, the discussion of the potential effects of their widespread use in the consumer and industrial products are just beginning to emerge. This review provides comprehensive analysis of data available on health effects of nanomaterials.</description>
        <link>http://www.jnanobiotechnology.com/content/2/1/12</link>
                <dc:creator>Peter Hoet</dc:creator>
                <dc:creator>Irene Bruske-Hohlfeld</dc:creator>
                <dc:creator>Oleg Salata</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2004, 2:12</dc:source>
        <dc:date>2004-12-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-2-12</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>2</prism:volume>
        <prism:startingPage>12</prism:startingPage>
        <prism:publicationDate>2004-12-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/8/1/2">
        <title>Optical characterization of colloidal CdSe quantum dots in endothelial progenitor cells</title>
        <description>We have quantitatively analyzed the confocal spectra of colloidal quantum dots (QDs) in rat endothelial progenitor cells (EPCs) by using Leica TCS SP5 Confocal Microscopy System. Comparison of the confocal spectra of QDs located inside and outside EPCs revealed that the interaction between the QDs and EPCs effectively reduces the radius of the exciton confinement inside the QDs so that the excitonic energy increases and the QD fluorescence peak blueshifts. Furthermore, the EPC environment surrounding the QDs shields the QDs so that the excitation of the QDs inside the cells is relatively weak, whereas the QDs outside the cells can be highly excited. At high excitations, the occupation of the ground excitonic state in the QD outside the cells becomes saturated and high-energy states excited, resulting in a large relaxation energy and a broad fluorescence peak. This permits, in concept, to use QD biomarkers to monitor EPCs by characterizing QD fluorescence spectra.</description>
        <link>http://www.jnanobiotechnology.com/content/8/1/2</link>
                <dc:creator>Matyas Molnar</dc:creator>
                <dc:creator>Ying Fu</dc:creator>
                <dc:creator>Peter Friberg</dc:creator>
                <dc:creator>Yun Chen</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2010, 8:2</dc:source>
        <dc:date>2010-02-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-8-2</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>2</prism:startingPage>
        <prism:publicationDate>2010-02-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/7/1/8">
        <title>Silver nanoparticles inhibit VEGF-and IL-1beta-induced vascular permeability via Src dependent pathway in porcine retinal endothelial cells</title>
        <description>The aim of this study is to determine the effects of silver nanoparticles (Ag-NP) on vascular endothelial growth factor (VEGF)-and interleukin-1 beta (IL-1&#946;)-induced vascular permeability, and to detect the underlying signaling mechanisms involved in endothelial cells. Porcine retinal endothelial cells (PRECs) were exposed to VEGF, IL-1&#946; and Ag-NP at different combinations and endothelial cell permeability was analyzed by measuring the flux of RITC-dextran across the PRECs monolayer. We found that VEGF and IL-1&#946; increase flux of dextran across a PRECs monolayer, and Ag-NP block solute flux induced by both VEGF and IL-1&#946;. To explore the signalling pathway involved VEGF- and IL-1&#946;-induced endothelial alteration, PRECs were treated with Src inhibitor PP2 prior to VEGF and IL-1&#946; treatment, and the effects were recorded. Further, to clarify the possible involvement of the Src pathways in endothelial cell permeability, plasmid encoding dominant negative(DN) and constitutively active(CA) form of Src kinases were transfected into PRECs, 24 h prior to VEGF and IL-1&#946; exposure and the effects were recorded. Overexpression of DN Src blocked both VEGF-and IL-1&#946;-induced permeability, while overexpression of CA Src rescues the inhibitory action of Ag-NP in the presence or absence of VEGF and IL-1&#946;. Further, an in vitro kinase assay was performed to identify the presence of the Src phosphorylation at Y419. We report that VEGF and IL-1&#946;-stimulate endothelial permeability via Src dependent pathway by increasing the Src phosphorylation and Ag-NP block the VEGF-and IL-1&#946;-induced Src phosphorylation at Y419. These results demonstrate that Ag-NP may inhibit the VEGF-and IL-1&#946;-induced permeability through inactivation of Src kinase pathway and this pathway may represent a potential therapeutic target to inhibit the ocular diseases such as diabetic retinopathy.</description>
        <link>http://www.jnanobiotechnology.com/content/7/1/8</link>
                <dc:creator>Sardarpasha Sheikpranbabu</dc:creator>
                <dc:creator>Kalimuthu Kalishwaralal</dc:creator>
                <dc:creator>Deepak Venkataraman</dc:creator>
                <dc:creator>Soo Hyun Eom</dc:creator>
                <dc:creator>Jongsun Park</dc:creator>
                <dc:creator>Sangiliyandi Gurunathan</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2009, 7:8</dc:source>
        <dc:date>2009-10-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-7-8</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>8</prism:startingPage>
        <prism:publicationDate>2009-10-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/7/1/9">
        <title>Intein-mediated site-specific conjugation of Quantum Dots to proteins in vivo</title>
        <description>We describe an intein based method to site-specifically conjugate Quantum Dots (QDs) to target proteins in vivo. This approach allows the covalent conjugation of any nanostructure and/or nanodevice to any protein and thus the targeting of such material to any intracellular compartment or signalling complex within the cells of the developing embryo. We genetically fused a pleckstrin-homology (PH) domain with the N-terminus half of a split intein (IN). The C-terminus half (IC) of the intein was conjugated to QDs in vitro. IC-QD&apos;s and RNA encoding PH-IN were microinjected into Xenopus embryos. In vivo intein-splicing resulted in fully functional QD-PH conjugates that could be monitored in real time within live embryos. Use of Near Infra Red (NIR)-emitting QDs allowed monitoring of QD-conjugates within the embryo at depths where EGFP is undetectable demonstrating the advantages of QD&apos;s for this type of experiment. In conclusion, we have developed a novel in vivo methodology for the site-specific conjugation of QD&apos;s and other artificial structures to target proteins in different intracellular compartments and signaling complexes.</description>
        <link>http://www.jnanobiotechnology.com/content/7/1/9</link>
                <dc:creator>Anna Charalambous</dc:creator>
                <dc:creator>Maria Andreou</dc:creator>
                <dc:creator>Paris Skourides</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2009, 7:9</dc:source>
        <dc:date>2009-12-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-7-9</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>7</prism:volume>
        <prism:startingPage>9</prism:startingPage>
        <prism:publicationDate>2009-12-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/8/1/3">
        <title>A signal amplification assay for HSV type 1 viral DNA detection using nanoparticles and direct acoustic profiling</title>
        <description>Background:
Nucleic acid based recognition of viral sequences can be used together with label-free biosensors to provide rapid, accurate confirmation of viral infection. To enhance detection sensitivity, gold nanoparticles can be employed with mass-sensitive acoustic biosensors (such as a quartz crystal microbalance) by either hybridising nanoparticle-oligonucleotide conjugates to complimentary surface-immobilised ssDNA probes on the sensor, or by using biotin-tagged target oligonucleotides bound to avidin-modified nanoparticles on the sensor. We have evaluated and refined these signal amplification assays for the detection from specific DNA sequences of Herpes Simplex Virus (HSV) type 1 and defined detection limits with a 16.5 MHz fundamental frequency thickness shear mode acoustic biosensor.
Results:
In the study the performance of semi-homogeneous and homogeneous assay formats (suited to rapid, single step tests) were evaluated utilising different diameter gold nanoparticles at varying DNA concentrations. Mathematical models were built to understand the effects of mass transport in the flow cell, the binding kinetics of targets to nanoparticles in solution, the packing geometries of targets on the nanoparticle, the packing of nanoparticles on the sensor surface and the effect of surface shear stiffness on the response of the acoustic sensor. This lead to the selection of optimised 15 nm nanoparticles that could be used with a 6 minute total assay time to achieve a limit of detection sensitivity of 5.2 &#215; 10-12 M. Larger diameter nanoparticles gave poorer limits of detection than smaller particles. The limit of detection was three orders of magnitude lower than that observed using a hybridisation assay without nanoparticle signal amplification.
Conclusions:
An analytical model was developed to determine optimal nanoparticle diameter, concentration and probe density, which allowed efficient and rapid optimisation of assay parameters. Numerical analysis and subsequent associated experimental data suggests that the response of the mass sensitive biosensor system used in conjunction with captured particles was affected by i) the coupled mass of the particle, ii) the proximal contact area between the particle and the sensor surface and iii) the available capture area on the particle and binding dynamics to this capture area. The latter two effects had more impact on the detection limit of the system than any potential enhancement due to added mass from a larger nanoparticle.</description>
        <link>http://www.jnanobiotechnology.com/content/8/1/3</link>
                <dc:creator>Yildiz Uludag</dc:creator>
                <dc:creator>Richard Hammond</dc:creator>
                <dc:creator>Matthew Cooper</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2010, 8:3</dc:source>
        <dc:date>2010-02-14T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-8-3</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>8</prism:volume>
        <prism:startingPage>3</prism:startingPage>
        <prism:publicationDate>2010-02-14T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.jnanobiotechnology.com/content/4/1/10">
        <title>Three-dimensional reconstruction of cell nuclei, internalized quantum dots and sites of lipid peroxidation</title>
        <description>Background:
The purpose of the study was to develop and illustrate three-dimensional (3-D) reconstruction of nuclei and intracellular lipid peroxidation in cells exposed to oxidative stress induced by quantum dots. Programmed cell death is characterized by multiple biochemical and morphological changes in different organelles, including nuclei, mitochondria and lysosomes. It is the dynamics of the spatio-temporal changes in the signalling and morphological adaptations which will ultimately determine the &apos;shape&apos; and fate of the cell.
Results:
We present new approaches to the 3-D reconstruction of organelle morphology and biochemical changes in confocal live-cell images. We demonstrate the 3-D shapes of nuclei, the 3-D intracellular distributions of QDs and the accompanying lipid-membrane peroxidation, and provide methods for quantification.
Conclusion:
This study provides an approach to 3-D organelle and nanoparticle visualization in the context of cell death; however, this approach is also applicable more generally to investigating changes in organelle morphology in response to therapeutic interventions, stressful stimuli and internalized nanoparticles. Moreover, the approach provides quantitative data for such changes, which will help us to better integrate compartmentalization of subcellular events and to link morphological and biochemical changes with physiological outcomes.</description>
        <link>http://www.jnanobiotechnology.com/content/4/1/10</link>
                <dc:creator>W. Robert J. Funnell</dc:creator>
                <dc:creator>Dusica Maysinger</dc:creator>
                <dc:source>Journal of Nanobiotechnology 2006, 4:10</dc:source>
        <dc:date>2006-10-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1477-3155-4-10</dc:identifier>
        <prism:publicationName>Journal of Nanobiotechnology</prism:publicationName>
        <prism:issn>1477-3155</prism:issn>
        <prism:volume>4</prism:volume>
        <prism:startingPage>10</prism:startingPage>
        <prism:publicationDate>2006-10-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
